- Home
- NKTX vs MRCC Comparison
NKTX vs MRCC Comparison
Compare NKTX & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- MRCC
- Stock Information
- Founded
- NKTX 2015
- MRCC 2011
- Country
- NKTX United States
- MRCC United States
- Employees
- NKTX N/A
- MRCC N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- NKTX Health Care
- MRCC Finance
- Exchange
- NKTX Nasdaq
- MRCC Nasdaq
- Market Cap
- NKTX 170.8M
- MRCC 176.4M
- IPO Year
- NKTX 2020
- MRCC 2012
- Fundamental
- Price
- NKTX $2.00
- MRCC $7.70
- Analyst Decision
- NKTX Strong Buy
- MRCC Hold
- Analyst Count
- NKTX 6
- MRCC 1
- Target Price
- NKTX $15.00
- MRCC $8.00
- AVG Volume (30 Days)
- NKTX 2.4M
- MRCC 78.2K
- Earning Date
- NKTX 03-26-2025
- MRCC 05-07-2025
- Dividend Yield
- NKTX N/A
- MRCC 12.99%
- EPS Growth
- NKTX N/A
- MRCC 2515.72
- EPS
- NKTX N/A
- MRCC 0.45
- Revenue
- NKTX N/A
- MRCC $60,527,000.00
- Revenue This Year
- NKTX N/A
- MRCC N/A
- Revenue Next Year
- NKTX N/A
- MRCC N/A
- P/E Ratio
- NKTX N/A
- MRCC $17.16
- Revenue Growth
- NKTX N/A
- MRCC N/A
- 52 Week Low
- NKTX $1.31
- MRCC $7.01
- 52 Week High
- NKTX $11.84
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- NKTX 59.36
- MRCC 35.40
- Support Level
- NKTX $1.31
- MRCC $7.70
- Resistance Level
- NKTX $2.34
- MRCC $7.89
- Average True Range (ATR)
- NKTX 0.15
- MRCC 0.16
- MACD
- NKTX 0.05
- MRCC -0.02
- Stochastic Oscillator
- NKTX 66.99
- MRCC 13.24
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.